<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643551</url>
  </required_header>
  <id_info>
    <org_study_id>1204M12861</org_study_id>
    <nct_id>NCT01643551</nct_id>
  </id_info>
  <brief_title>Neuron Specific Enolase in Ventricular Assist Device Recipients</brief_title>
  <acronym>NSE-LVAD</acronym>
  <official_title>Neuron Specific Enolase in Ventricular Assist Device Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study of neuron specific enolase, as a marker of reperfusion injury, in LVAD
      recipients before and following VAD implantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients eligible for left ventricular assist device (LVAD) typically have severe heart
      failure, which is characterized by poor cardiac output. The relatively abrupt increase in
      cardiac output that follows implant of a LVAD may cause reperfusion injury. Furthermore,
      selected patients may have particularly severe consequences of such injury, including
      refractory acidosis and vasoplegia. Neuron specific enolase (NSE) has been established as a
      biomarker of reperfusion injury. We hypothesize that changes in NSE following LVAD will be
      greater than the changes in NSE noted in a control population of patients undergoing non-VAD
      cardiac surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neuron-Specific Enolase</measure>
    <time_frame>Pre and post-surgery</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Advanced Heart Failure</condition>
  <condition>Left Ventrucular Assist Device</condition>
  <arm_group>
    <arm_group_label>LVAD Group</arm_group_label>
    <description>18 years and older Planning to undergo VAD implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiac Surgery Group</arm_group_label>
    <description>18 years or older Planning to undergo valve or coronary bypass surgery</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiovascular Surgical candidates from outpatient cardiology clinic or inpatient service.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Group 1 - Pre-VAD implantation patients

          -  18 years and older

          -  lanning to undergo VAD implantation Group 2 Cardiac Surgery Comparison Group

          -  18 years or older

          -  Planning to undergo valve or coronary bypass surgery

        Exclusion Criteria:

          -  Acute cerebrovascular infarction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter M Eckman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Demitri Yannopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota Medical Center-Fairview</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2012</study_first_posted>
  <last_update_submitted>December 16, 2014</last_update_submitted>
  <last_update_submitted_qc>December 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Left Ventricular Assist Device</keyword>
  <keyword>Reperfusion Injury</keyword>
  <keyword>Neuron Specific Enolase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

